# Neurotherapeutics (Neurotherapeutics Ltd) Private limited company registered in Nottingham, classed under “Manufacture of irradiation, electromedical and electrotherapeutic equipment”. - Company number: 13198315 - Status: Active - Type: Private limited company - Incorporated: 12 February 2021 - Registered office: The Ingenuity Centre University Of Nottingham Innovation Park, Triumph Road, Nottingham, NG7 2TU - Location: Nottingham - Activity: Manufacture of irradiation, electromedical and electrotherapeutic equipment ## Latest filed profit No profit figure in its latest filed accounts. Turnover, net assets, cash, staff, earlier years, ratios and owners are on the page for subscribers. ## Questions people ask ### What does Neurotherapeutics do? Private limited company registered in Nottingham, classed under “Manufacture of irradiation, electromedical and electrotherapeutic equipment”. ### How much turnover does Neurotherapeutics make? Answered on the page for FirmFacts Pro subscribers: https://firmfacts.co/company/neurotherapeutics-13198315 ### Is Neurotherapeutics profitable? Neurotherapeutics's profit isn't public: small companies may file without a profit and loss account. ### How many people work at Neurotherapeutics? Answered on the page for FirmFacts Pro subscribers: https://firmfacts.co/company/neurotherapeutics-13198315 ### Who runs and owns Neurotherapeutics? Its directors are Georgina Margaret Jackson, Barbara Morera Maiquez, Karl Moss, David John O'Reilly, Ian Rhodes. Its owners are shown to subscribers. ### Where is Neurotherapeutics based? Its registered office is The Ingenuity Centre University Of Nottingham Innovation Park, Triumph Road, Nottingham, NG7 2TU, in Nottingham. ### When was Neurotherapeutics founded? Neurotherapeutics Ltd was incorporated on 12 February 2021. ### Is Neurotherapeutics still trading? The register lists Neurotherapeutics Ltd as active. ## Timeline Recent filings and changes at Companies House. - 2026-10-18: Termination of appointment of Paul Michael Cable as a director on 2 October 2026 - 2026-04-30: Statement of capital following an allotment of shares on 21 April 2026 · GBP 2,867.19862 (and 12 more like it since 15 July 2021) - 2026-04-28: Total exemption full accounts made up to 31 December 2025 - 2026-03-18: Termination of appointment of Andrew Paul Mcneill as a director on 16 March 2026 - 2026-01-30: Resolutions (and 4 more like it since 29 July 2021) - 2026-01-30: Memorandum and Articles of Association (and 3 more like it since 20 August 2021) - 2025-07-23: Total exemption full accounts made up to 31 December 2024 - 2024-10-01: Appointment of Mr David John O'reilly as a director on 1 September 2024 - 2024-09-30: Appointment of Mr Karl Moss as a director on 1 September 2024 - 2024-07-16: Second filing of a statement of capital following an allotment of shares on 20 June 2024 · GBP 1,888.11862 (and 3 more like it since 9 March 2022) - 2024-05-16: Total exemption full accounts made up to 31 December 2023 - 2024-03-04: Change of share class name or designation (and 1 more like it since 10 January 2024) - 2024-03-01: Termination of appointment of Stephen Raymond Jackson as a director on 28 February 2024 - 2024-03-01: Termination of appointment of James Stuart Duncan as a director on 21 February 2024 - 2024-02-29: Appointment of Andrew Mcneill as a director on 8 February 2024 - 2023-06-07: Total exemption full accounts made up to 31 December 2022 - 2023-02-09: Director's details changed for Dr Barbara Morera Maiquez on 1 February 2023 - 2023-01-31: Appointment of Mr Paul Michael Cable as a director on 31 January 2023 - 2022-12-06: Appointment of Dr Barbara Morera Maiquez as a director on 1 December 2022 - 2022-06-22: Appointment of Mr Ian Rhodes as a director on 1 January 2022 - 2022-05-24: Total exemption full accounts made up to 31 December 2021 - 2022-01-28: Notification of a person with significant control statement - 2022-01-28: Cessation of Barbara Morera Maiquez as a person with significant control on 5 August 2021 - 2022-01-28: Cessation of Stephen Raymond Jackson as a person with significant control on 5 August 2021 - 2022-01-28: Cessation of Georgina Margaret Jackson as a person with significant control on 5 August 2021 --- Source: Companies House filings (Open Government Licence v3.0). Figures are as filed; nothing is estimated. Page: https://firmfacts.co/company/neurotherapeutics-13198315